LEO Pharma Applies for Gel Formulation for Dovobet

February 28, 2017
LEO Pharma filed on February 27 an application for a gel formulation for the plaque psoriasis treatment Dovobet (calcipotriol hydrate + betamethasone dipropionate) in Japan. Dovobet is currently marketed in an ointment formulation, but the company developed a gel formulation...read more